The first tubeless, waterproof AID system is approved in Canada for people with type 1 diabetes ages two years and above. In Canada, it pairs with the Dexcom G6 and G7 continuous glucose monitor (CGM) systems to automatically deliver insulin.

Currently, Ontario and Nova Scotia have public reimbursement in place for Omnipod 5 in Canada. Insulet intends to expand coverage across additional provinces and territories throughout the country.

Omnipod 5 is the company’s latest-generation insulin delivery system. A small, discreet, tubeless, wearable patch pump, Omnipod 5 features SmartAdjust technology that uses CGM readings to predict where glucose will be 60 minutes into the future. It then increases, decreases, or pauses insulin delivery based on the user’s desired and customized glucose target.